Haberkorn U - Search Results

1

Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.

Haberkorn U, Altmann A, Kamencic H, Morr I, Traut U, Henze M, Jiang S, Metz J, Kinscherf R. Haberkorn U, et al. Eur J Nucl Med. 2001 Nov;28(11):1690-6. doi: 10.1007/s002590100644. Eur J Nucl Med. 2001. PMID: 11702112

2

Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.

Haberkorn U, Reinhardt M, Strauss LG, Oberdorfer F, Berger MR, Altmann A, Wallich R, Dimitrakopoulou A, van Kaick G. Haberkorn U, et al. J Nucl Med. 1992 Nov;33(11):1981-7. J Nucl Med. 1992. PMID: 1432159 Free article.

3

Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.

Haberkorn U, Morr I, Oberdorfer F, Bellemann ME, Blatter J, Altmann A, Kahn B, van Kaick G. Haberkorn U, et al. J Nucl Med. 1994 Nov;35(11):1842-50. J Nucl Med. 1994. PMID: 7965167 Free article.

4

Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.

Haberkorn U, Oberdorfer F, Gebert J, Morr I, Haack K, Weber K, Lindauer M, van Kaick G, Schackert HK. Haberkorn U, et al. J Nucl Med. 1996 Jan;37(1):87-94. J Nucl Med. 1996. PMID: 8544010 Free article.

5

Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.

Schaider H, Haberkorn U, Berger MR, Oberdorfer F, Morr I, van Kaick G. Schaider H, et al. Among authors: haberkorn u. Eur J Nucl Med. 1996 Jan;23(1):55-60. doi: 10.1007/BF01736990. Eur J Nucl Med. 1996. PMID: 8586103

6

Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description.

Ziegler SI, Haberkorn U, Byrne H, Tong C, Kaja S, Richolt JA, Byrne H, Tong C, Schosser R, Krieter H, Kaja S, Richolt JA, Lammertsma AA, Price P. Ziegler SI, et al. Among authors: haberkorn u. Eur J Nucl Med. 1996 Feb;23(2):169-77. doi: 10.1007/BF01731841. Eur J Nucl Med. 1996. PMID: 8925852

7

Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.

Brix G, Bellemann ME, Haberkorn U, Gerlach L, Lorenz WJ. Brix G, et al. Among authors: haberkorn u. Nucl Med Biol. 1996 Oct;23(7):897-906. doi: 10.1016/s0969-8051(96)00122-9. Nucl Med Biol. 1996. PMID: 8971857

8

Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.

Haberkorn U, Altmann A, Morr I, Knopf KW, Germann C, Haeckel R, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Feb;38(2):287-94. J Nucl Med. 1997. PMID: 9025757 Free article.

9

Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.

Haberkorn U, Altmann A, Morr I, Germann C, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Jul;38(7):1048-54. J Nucl Med. 1997. PMID: 9225789 Free article.

10

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.

Haberkorn U, Ziegler SI, Oberdorfer F, Trojan H, Haag D, Peschke P, Berger MR, Altmann A, van Kaick G. Haberkorn U, et al. Nucl Med Biol. 1994 Aug;21(6):827-34. doi: 10.1016/0969-8051(94)90162-7. Nucl Med Biol. 1994. PMID: 9234332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters